XGN
Exagen Inc
NASDAQ: XGN · HEALTHCARE · DIAGNOSTICS & RESEARCH
$2.90
+5.07% today
Updated 2026-04-30
Market cap
$65.91M
P/E ratio
—
P/S ratio
0.99x
EPS (TTM)
$-0.93
Dividend yield
—
52W range
$3 – $12
Volume
0.3M
Exagen Inc (XGN) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $926000.00 | $3.06M | $11.66M | $17.95M | $26.81M | $32.44M | $40.39M | $41.98M | $48.30M | $45.56M | $52.55M | $55.64M | $66.58M |
| Revenue growth (YoY) | — | +229.9% | +281.8% | +53.9% | +49.4% | +21.0% | +24.5% | +3.9% | +15.1% | -5.7% | +15.3% | +5.9% | +19.7% |
| Cost of revenue | $1.97M | $2.83M | $6.88M | $9.53M | $14.14M | $15.38M | $18.81M | $16.56M | $20.59M | $24.21M | $23.09M | $22.53M | $27.78M |
| Gross profit | $-1.05M | $225000.00 | $4.78M | $8.41M | $12.67M | $17.06M | $21.58M | $25.42M | $27.71M | $21.35M | $29.46M | $33.11M | $38.80M |
| Gross margin | -113.2% | 7.4% | 41.0% | 46.9% | 47.3% | 52.6% | 53.4% | 60.6% | 57.4% | 46.9% | 56.1% | 59.5% | 58.3% |
| R&D | $1.05M | $897000.00 | $1.29M | $1.37M | $1.55M | $2.13M | $2.18M | $3.57M | $7.24M | $9.88M | $4.87M | $5.38M | $6.25M |
| SG&A | $4.86M | $6.56M | $13.97M | $15.91M | $17.52M | $18.27M | $27.10M | $35.73M | $42.84M | $49.02M | $45.93M | $39.97M | $46.62M |
| Operating income | $-6.83M | $-9.14M | $-11.56M | $-10.39M | $-7.84M | $-4.88M | $-9.30M | $-15.19M | $-24.07M | $-46.05M | $-22.84M | $-13.64M | $-14.07M |
| Operating margin | -737.1% | -299.3% | -99.1% | -57.9% | -29.2% | -15.0% | -23.0% | -36.2% | -49.8% | -101.1% | -43.5% | -24.5% | -21.1% |
| EBITDA | $-6.42M | $-12.06M | $-11.49M | $-13.55M | $-22.56M | $-4.36M | $-7.93M | $-13.65M | $-23.10M | $-43.66M | $-19.15M | $-11.14M | $-11.95M |
| EBITDA margin | -693.5% | -394.7% | -98.6% | -75.5% | -84.2% | -13.4% | -19.6% | -32.5% | -47.8% | -95.8% | -36.4% | -20.0% | -18.0% |
| EBIT | $-6.82M | $-12.51M | $-12.05M | $-14.43M | $-23.23M | $-5.09M | $-8.52M | $-14.20M | $-24.05M | $-45.22M | $-21.32M | $-12.87M | $-14.07M |
| Interest expense | $463000.00 | $941000.00 | $2.94M | $4.50M | $2.95M | $2.87M | $3.49M | $2.56M | $2.63M | $2.45M | $2.33M | $2.23M | $4.32M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-7.32M | $-13.50M | $-14.98M | $-19.18M | $-25.63M | $-8.01M | $-12.04M | $-16.69M | $-26.85M | $-47.39M | $-23.69M | $-15.12M | $-19.95M |
| Net income growth (YoY) | — | -84.3% | -11.0% | -28.0% | -33.6% | +68.7% | -50.2% | -38.6% | -60.9% | -76.5% | +50.0% | +36.2% | -32.0% |
| Profit margin | -790.9% | -441.8% | -128.4% | -106.9% | -95.6% | -24.7% | -29.8% | -39.8% | -55.6% | -104.0% | -45.1% | -27.2% | -30.0% |